Double Finalists at the 2022 ๐—™๐—ถ๐—ฒ๐—ฟ๐—ฐ๐—ฒ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜๐—ถ๐—ป๐—ด ๐—”๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€

  •  14 July, 2022
  •  

  • Love it

Our work was also recently shortlisted for the ๐—™๐—ถ๐—ฒ๐—ฟ๐—ฐ๐—ฒ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜๐—ถ๐—ป๐—ด ๐—”๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€ 2022, where the jury selected our #PatientCasePlayer and the #ClinicalPaper #WebApplication as one of the best entries under the ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—–๐—ต๐—ฎ๐—น๐—น๐—ฒ๐—ป๐—ด๐—ฒ category. #FiercePharma #FiercePharmaMarketing #MarketingAwards

Find more details here: https://lnkd.in/gHRrdi5J




Comments

Comments

Post a Comment

Please enter valid name.
Please enter valid email id.
please turn your device